Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03586596 · ClinicalTrials.gov registry record · NA
Mobile Cessation Support for Latino Smokers
A NA study, sponsored by University of Rochester.
- Completed
- Registry status
- NA
- Development phase
- 457
- Enrollment target
NCT03586596 is a NA study that has completed, run by University of Rochester. The registered enrollment target is 457 participants.
The verdict
NCT03586596, a NA study, has completed, sponsored by University of Rochester.
- COMPLETED
- Registry status
- NA
- Development phase
- 457 participants
- Enrollment target
Study Summary
The primary aim of this study is to examine the efficacy of Decídetexto, an innovative mobile smoking cessation intervention that incorporates two elements: 1) a tablet-based e-Health platform that collects personal smoking-related information to support the development of an individualized quit plan and guides the ensuing text messaging program; and 2) a 12-week text messaging "skills-based counseling" (I.e, behavioral support) program that includes educational information, behavioral strategies, motivational messaging, and pharmacotherapy support driven by information obtained from both the tablet program and the user's text messages. The investigators will evaluate its efficacy relative to a standard care condition that provides high quality printed smoking cessation materials along with referral to telephone quit line counseling. Participants in both groups are given access to free pharmacotherapy via a toll-free study number. Experienced Promotores de Salud (Community Health Workers) will use community and clinic-based outreach to recruit Latino smokers into the study. Participants in both conditions will complete follow-up assessment at the end of treatment (Week 12) and Month 6 (primary outcome). Our hypothesis is that at month 6, smokers in Decídetexto will have significantly higher cotinine-verified 7-day point prevalence abstinence (no cigarettes in the past 7 days) than smokers in the control arm.
Interventions
- BEHAVIORAL Standard Care Control
- BEHAVIORAL The Decídetext program
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 457 participants |
| Start Date | 2018-09-01 |
| Est. Completion | 2021-09-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03586596
The ClinicalTrials.gov registry entry for NCT03586596 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 457 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Rochester, which has 636 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Standard Care Control is the first listed.
NCT03586596 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03586596 about?
NCT03586596 is a clinical study titled "Mobile Cessation Support for Latino Smokers". The primary aim of this study is to examine the efficacy of Decídetexto, an innovative mobile smoking cessation intervention that incorporates two elements: 1) a tablet-based e-Health platform that collects personal smoking-related information to support the development of an individualized quit pla...
What is the current status of trial NCT03586596?
This trial is currently completed. It is a NA study. The enrollment target is 457 participants. The study started on 2018-09-01. Estimated completion is 2021-09-08.
What interventions are being tested in trial NCT03586596?
The interventions under investigation include: Standard Care Control (BEHAVIORAL), The Decídetext program (BEHAVIORAL).
Who is sponsoring clinical trial NCT03586596?
This trial is sponsored by University of Rochester, which has 636 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.